Brief: Ceapro Inc Reports 2020 Q3 And Nine-Month Financial Results And Operational Highlights
27/11/2020 14:20
Nov 27 (Reuters) - Ceapro Inc CZO.V :
* . REPORTS 2020 THIRD QUARTER AND NINE-MONTH FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
* Q3 SALES ROSE 20 PERCENT TO C$3.476 MILLION
Source text for Eikon: ID:nGNX89w5JM
Further company coverage: CZO.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ceapro
See all newsBrief: Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
Brief: Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris
Brief: Aeterna Zentaris And Ceapro Announce Merger Of Equals To Create Diversified Biopharmaceutical Company
Brief: Ceapro Inc. Reports 2023 Third Quarter And Nine-Month Financial Results And Operational Highlights
Brief: Ceapro Initiates Phase 1-2A Study Assessing Avenanthramides For Potential Applications In Inflammation Based Diseases